当前位置: 首页 > 期刊 > 《中国现代医生》 > 2019年第26期
编号:13406669
麝香保心丸预防糖尿病患者冠脉支架术后再狭窄的临床效果分析(4)
http://www.100md.com 2019年9月15日 《中国现代医生》 2019年第26期
     [14] 徐晓红,沈利水,汤益民,等.麝香保心丸对急性心肌梗死患者PCI术后短期心功能及生活质量的影响[J].心电与循环,2018,37(3):21-24,38.

    [15] Zhang M,Zheng WP,Yang M,et al. Association between plasma BMP-2 and in-stent restenosis in patients with coronary artery disease[J].Clinica Chimica Acta,2017,471(9):150.

    [16] Kokkinidis DG,Waldo SW,Armstrong EJ. Treatment of coronary artery in-stent restenosis[J]. Expert Review of Cardiovascular Therapy,2017,15(3):191.

    [17] Murat SN,Yarlioglues M,Celik IE,et al.The relationship between lymphocyte-to-monocyte ratio and bare-metal stent in-stent restenosis in patients with stable coronary artery disease[J]. Clin Appl Thromb Hemost,2017,23(3):235-240.

    [18] Husain SS,Ahmed CM,Adhikary AB,et al. Coronary artery bypass graft with endarterectomy and stent removal in patient with multivessel in stent restenosis[J]. Mymensingh Medical Journal Mmj,2017,26(3):680.

    [19] Alraies MC,Darmoch F,Tummala R,et al.Diagnosis and management challenges of in-stent restenosis in coronary arteries[J]. World Journal of Cardiology,2017,9(8):640-651.

    [20] 胡小清,謝清,王荣锋,等.曲美他嗪联合麝香保心丸治疗急性心肌梗死的效果研究[J].现代生物医学进展,2017,17(21):4124-4127.

    (收稿日期:2019-03-28), http://www.100md.com(张伟 梅益斌 喻晖)
上一页1 2 3 4